MRNA Trade on Apr 2, 2020 14:03 from beno: Tradervue User Stock Trades.

Shared by
beno

Fundamentals

N/a

Catalysts / News / Painting the picture

-Corona virus sympathy
-Health officials say virus vaccine development has 'no glitches'
-Feb 11 2020: $500m IPO @ $19 per share
-mRNA-1273 coronavirus vaccine sent for testing
-March 16 2020: First human trial of COVID-19 vaccine

Technical Analysis

-Intraday pattern: Runner
-Levels: 30, 31.30, 32, 33

Original Plan / Strategy

First test long of 32.70, no confluence

Review

Was only supposed to long with 2 lots ( 2x 50 shares) but instead went full size and had to stop when 32.50 broke.

Execution detail:

Date/time	Symbol	Side	Price	Position
2020-04-02 14:03:33	MRNA	buy	$32.590	long
2020-04-02 14:05:32	MRNA	buy	$32.570	long
2020-04-02 14:05:43	MRNA	sell	$32.360	0

#chart1 { background-image:url('/shared/charts/pricechart?symbol=MRNA&trade=13679043&end=20200402143443&i=m1&TimeRange=90&Volume=1&ChartType=candlestick&width=450&height=275');}

#chart2 { background-image:url('/shared/charts/pricechart?symbol=MRNA&trade=13679043&end=20200402153543&i=m3&TimeRange=90&Volume=1&ChartType=candlestick&width=450&height=275');}

#chart3 { background-image:url('/shared/charts/pricechart?symbol=MRNA&trade=13679043&end=20200402160000&i=m15&TimeRange=90&Volume=1&ChartType=candlestick&width=450&height=275');}

#chart4 { background-image:url('/shared/charts/pricechart?symbol=MRNA&trade=13679043&end=20200502&i=d&TimeRange=120&Volume=1&ChartType=candlestick&width=450&height=275');}